RUVALIZUMAB IN THE TREATMENT OF COMPLEMENT-MEDIATED THROMBOTIC MICROANGIOPATHY (CM-TMA) POST ORGAN TRANSPLANT

被引：0
|
作者：
Pasala, Sphoorthy [1 ]
Yamada, Karla Sofia [1 ]
Madken, Mohit [1 ]
Jacer, Ahmad [1 ]
Muhsin, Saif A. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Boston, MA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2024年 / 83卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
143
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [1] Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
    Cammett, Tobin J.
    Garlo, Katherine
    Millman, Ellen E.
    Rice, Kara
    Toste, Catherine M.
    Faas, Susan J.
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (01) : 61 - 74
  • [2] Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
    Tobin J. Cammett
    Katherine Garlo
    Ellen E. Millman
    Kara Rice
    Catherine M. Toste
    Susan J. Faas
    Molecular Diagnosis & Therapy, 2023, 27 : 61 - 74
  • [3] Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
    Tobin J Cammett
    Katherine Garlo
    Ellen E Millman
    Kara Rice
    Catherine M Toste
    Susan J. Faas
    Molecular Diagnosis & Therapy, 2023, 27 : 281 - 281
  • [4] Nephrological aspects of complement-mediated thrombotic microangiopathy
    Smirnov, A. V.
    Karunnaya, A. V.
    Dobronravov, V. A.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (06) : 34 - 40
  • [5] A Tricky Diagnosis of Complement-Mediated Thrombotic Microangiopathy
    Stone, Fehlin
    Oliver, James D.
    Watson, Maura A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 140 - 140
  • [6] Review of Thrombotic Microangiopathy (TMA), and Post-Renal Transplant TMA
    Ardalan, Mohammad Reza
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2006, 17 (02) : 235 - 244
  • [7] Complement-mediated thrombotic microangiopathy associated with lupus nephritis
    Park, Mi Hee
    Caselman, Nicholas
    Ulmer, Scott
    Weitz, Ilene Ceil
    BLOOD ADVANCES, 2018, 2 (16) : 2090 - 2094
  • [8] Post-Caesarean Shock, Anemia and Thrombocytopenia: A Case Report on Suspected Complement-mediated Thrombotic Microangiopathy (C-TMA)
    Bajracharya, Joshan Lal
    Baral, Pankaj
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 1348 - 1349
  • [9] Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab (vol 27, pg 61, 2023)
    Cammett, Tobin J.
    Garlo, Katherine
    Millman, Ellen E.
    Rice, Kara
    Toste, Catherine M.
    Faas, Susan J.
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (02) : 281 - 281
  • [10] Demystifying the Atypical Presentation of Complement-Mediated Thrombotic Microangiopathy
    Yasuda, Allysha
    Takamatsu, Chelsea
    Nocera, Meleesa
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345